Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced it has released the next segment on its CEO Corner, a platform featuring Walter Klemp, Chief Executive Officer.
Selected as a C-Further program with up to $1.1 million in non-dilutive, aggregate payments to advance IND-enabling development, with potential for meaningful double-digit downstream commercial ...
Chimeric antigen receptor T (CAR T) cell therapy represents a milestone in leukemia treatment. CAR T works by genetically engineering a chimeric antigen receptor on the surface of the patient's T ...
Chimeric antigen receptor T (CAR T) cell therapy represents a milestone in leukemia treatment. CAR T works by genetically ...
Acute myeloid leukemia (AML) is a particularly aggressive form of blood cancer that usually progresses rapidly if swift and intensive treatment is not applied. Although the disease can often be ...
Soheil Meshinchi, MD, PhD, a world leader in developing novel approaches to treating acute myeloid leukemia (AML), has been ...
A groundbreaking discovery could bring us closer to a cure for HIV. Scientists at Ulm University Hospital have identified a natural human protein, RBP4 — known for transporting vitamin A — that can ...
Add Yahoo as a preferred source to see more of our stories on Google. (Credit: Picture Alliance/Getty Images) An amazing study out of London has confirmed the efficacy of prior work that reprograms ...
Newly updated research shows incredible promise, but it's still just the beginning of the era of real cancer therapies. Share on Facebook (opens in a new window) Share on X (opens in a new window) ...
A new generation of targeted treatments and gentler chemotherapy options for older adults with a new diagnosis of acute myeloid leukemia (AML) is driving better survival and cure rates. The updated ...
Tyrosine kinase inhibitors (TKIs) have revolutionized CML treatment, offering more effective and better-tolerated options than previous therapies. Second- and third-generation TKIs address resistance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results